New research in the April 2024 issue of Journal of the National Comprehensive Cancer Network showcases the feasibility of improving early detection and prevention for pancreatic cancer. Global incidences of pancreatic cancer ...
Apr 16, 2024
0
2
In a 10-center study, microwave ablation offered progression-free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma (PTC), according to research ...
Apr 2, 2024
0
0
Pancreatic ductal adenocarcinoma (PDAC), that arises from pancreatic epithelial cells, is the most common form of pancreatic cancer, with a very high mortality rate. This elevated mortality is associated with the unique tumor ...
Dec 7, 2023
0
1
Ripretinib is a tyrosine kinase inhibitor that was approved by the United States FDA in 2020 for treatment of advanced gastrointestinal stromal tumor (GIST) in patients who received prior treatment with three or more tyrosine ...
Nov 6, 2023
0
0
Surgical removal of parts of the liver remains the only curative approach for patients with liver-specific cancer. An international team led by Patrick Starlinger from MedUni Vienna has developed a score that provides an ...
Nov 2, 2023
0
0
New research in the October 2023 issue of Journal of the National Comprehensive Cancer Network finds that intensive local-regional treatment to remove as much tumor as possible (known as "debulking"), in addition to standard ...
Oct 12, 2023
0
1
Electrodes designed to collect research data while also locating epileptic seizures in the brain perform about as well as electrodes designed solely to locate seizures, according to Rutgers and UCLA researchers.
Sep 7, 2023
0
1
Dr. Brett Youngerman and researchers from the Columbia Comprehensive Epilepsy Center have led the largest multicenter series to date of magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) recently published ...
Aug 31, 2023
0
2
Only 22% of Texas patients with early-stage pancreatic cancer received standard-of-care surgery to remove their tumors, researchers at UT Southwestern Medical Center report in a new study. The findings, published in the Journal ...
Jul 25, 2023
0
2
Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma (HCC) following surgical resection or ablation, according to the results ...
Apr 17, 2023
0
28
